EU Diphtheria Case Definition: Position Paper, 2002
Good surveillance is fundamental to every vaccination programme. The responsibility of public health authorities is to demonstrate that these programmes are effective, particularly in view of the susceptibility to diphtheria amongst adult populations in Europe and the demonstrated potential for diphtheria to re-emerge rapidly if vaccination coverage or efficacy falls1. Maintaining confidence by demonstrating safety and effectiveness is critical. However, the quality of diphtheria surveillance varies greatly between countries both at laboratory and public health levels, and standards need to be agreed and set, and methodologies harmonised across Europe. Furthermore, the standards need to be higher than for other diseases due to specific programmatic targets to demonstrate the absence of disease or to ascertain reliably low levels of disease incidence. In this way, vaccine preventable disease surveillance in high coverage countries, and diphtheria surveillance specifically, has particular requirements which may differ from some other European surveillance projects that have focused on high incidence diseases.
ECDC Evidence Brief: Pre-exposure prophylaxis for HIV prevention in Europe and Central Asia
28 Nov 2019 - This evidence brief summarises key issues and priorities for action in Europe and Central Asia on PrEP. It is largely based on data collected in 2018 and 2019 by the European Centre for Disease Prevention and Control (ECDC) to monitor implementation of the 2004 Dublin Declaration. The monitoring questionnaire was disseminated to the 53 countries that are part of the WHO European Region, plus Kosovo and Liechtenstein via an online survey.
HIV testing, Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia: 2018 progress report
27 Nov 2019 - This report presents the situation of HIV testing in Europe and Central Asia. It summarises data on implementation of national guidelines that shape HIV testing policies, the provision and uptake of HIV testing services in general and among key populations, and efforts being made to widen engagement with HIV testing and reduce late diagnosis.
External quality assessment of laboratory performance – European Antimicrobial Resistance Surveillance Network (EARS-Net), 2018
22 Nov 2019 - This report provides an analysis of the external quality assessment (EQA) performance with antimicrobial susceptibility testing (AST) of laboratories participating in the European Antimicrobial Resistance Surveillance Network in 2018. A total of 860 laboratories (1 – 114 per country) from 30 EU/EEA countries participated in the EQA exercise. Six bacterial strains were used: Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, Enterococcus faecium and Streptococcus pneumoniae.